Ultralife Corp (NASDAQ:ULBI) price on Thursday, July 03, rose 3.07% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.07.
A look at the stock’s price movement, the close in the last trading session was $8.8, moving within a range at $8.7 and $9.1. The beta value (5-Year monthly) was 0.911 while the PE ratio in trailing twelve months stood at 28.78. Turning to its 52-week performance, $12.40 and $4.07 were the 52-week high and 52-week low respectively. Overall, ULBI moved 25.10% over the past month.
Ultralife Corp’s market cap currently stands at around $150.86 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-09.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ULBI is a 100% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ULBI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ULBI’s current price about 10.79% and 38.86% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 71.12, while 7-day volatility ratio is 5.76% and 5.96% in the 30-day chart. Further, Ultralife Corp (ULBI) has a beta value of 1.01.
If we refocus on Ultralife Corp (NASDAQ:ULBI), historical trading data shows that trading volumes averaged 0.26 over the past 10 days and 119.05K over the past 3 months. The company’s latest data on shares outstanding shows there are 16.63 million shares.
The 39.50% of Ultralife Corp’s shares are in the hands of company insiders while institutional holders own 35.81% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.35 million on 2025-06-13, giving us a short ratio of 3.43. The data shows that as of 2025-06-13 short interest in Ultralife Corp (ULBI) stood at 352.0 of shares outstanding, with shares short rising to 0.31 million registered in 2025-05-15. Current price change has pushed the stock -11.51% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ULBI stock continues to rise going into the next quarter.
